Clinical

share

Danish drugmaker Novo Nordisk said on Friday a phase 2 trial for its big hope in tackling obesity, an improved...

share

Medidata and Median Technologies announced a new collaboration to streamline the growth and use of medical imaging in cancer clinical trials....

share

DURECT Corporation announced that patient enrollment has been completed in PERSIST, the pivotal Phase 3 clinical trial of...

1 shares

Enanta Pharmaceuticals, Inc., a research and development-focused biotechnology company dedicated to creating small molecule drugs for viral infections...

share

Zydus announced the initiation of a phase II trial investigating ZYAN1, an oral hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI),...

share

Astellas Pharma Inc. and Pfizer Inc. announced the amendment of the protocol for the registrational PROSPER trial, a...

share

US-based PureTech Health has signed a licensing and equity agreement with Swiss company Novartis to advance two clinical-stage...

share

Tracon Pharmaceuticals said that data from a phase 2 study demonstrated that a combination of its endoglin antibody...